Table 3.
Factors | Young Patients (<60y) | Elderly patients (≥60y) | ||||||
---|---|---|---|---|---|---|---|---|
Non-PC Group 242(%) | PC Group 52(%) | Univariate p | Multivariate p | Non-PC Group 394(%) | PC Group 154(%) | Univariate p | Multivariate p | |
Gender | 0.883 | 0.192 | ||||||
Male | 165(68.2) | 36(69.2) | 312(79.2) | 114(74.0) | ||||
Female | 77(31.8) | 16(30.8) | 82(20.8) | 40(26.0) | ||||
BMI (kg/m2) | 0.083 | 0.995 | ||||||
<23.9 | 194(80.2) | 36(69.2) | 302(76.6) | 118(76.6) | ||||
≥23.9 | 48(19.8) | 16(30.8) | 92(23.4) | 36(23.4) | ||||
Charison score | 0.001* | 0.150 | ||||||
0(0) | 122(50.4) | 31(59.6) | 120(30.5) | 40(26.0) | ||||
1(1–3) | 98(40.5) | 9(17.3) | 196(49.7) | 72(46.8) | ||||
2(4–6) | 22(9.1) | 12(23.1) | 78(19.8) | 42(27.2) | ||||
Preoperative anemia | 0.247 | 0.421 | ||||||
No | 229(94.6) | 47(90.4) | 357(90.6) | 136(88.3) | ||||
Yes | 13(5.4) | 5(9.6) | 37(9.4) | 18(11.7) | ||||
Preoperative bleeding No Yes |
234(96.7) 8(3.3) |
49(94.2) 3(5.8) |
0.396 |
378(95.9) 16(4.1) |
147(95.5) 7(4.5) |
0.799 | ||
Preoperative obstruction No Yes |
234(96.7) 8(3.3) |
51(98.1) 1(1.9) |
0.599 |
379(96.2) 15(3.8) |
147(95.5) 7(4.5) |
0.692 | ||
Hypertension No Yes |
208(86.0) 34(14.0) |
44(84.6) 8(15.4) |
0.803 |
260(66.0) 134(34.0) |
104(67.5) 50(32.5) |
0.731 | ||
Diabetes No Yes |
229(94.6) 13(5.4) |
49(94.2) 3(5.8) |
0.909 |
362(91.9) 32(8.1) |
133(86.4) 21(13.6) |
0.050* | 0.048* | |
Hyponatremia No Yes |
215(88.8) 27(11.2) |
48(92.3) 4(7.7) |
0.460 |
357(90.6) 37(9.4) |
122(79.2) 32(20.8) |
0.001* | 0.001* | |
Hypocalcemia No Yes |
209(86.4) 33(13.6) |
42(80.8) 10(19.2) |
0.300 |
312(79.2) 82(20.8) |
103(66.9) 51(33.1) |
0.003 | 0.038* | |
Albumin, g/L ≥100 <100 |
225(93.0) 17(7.0) |
49(94.2) 3(5.8) |
0.744 |
348(88.3) 46(11.7) |
136(88.3) 18(11.7) |
0.997 | ||
Hemoglobin, g/L ≥100 <100 |
207(85.5) 35(14.5) |
43(82.7) 9(17.3) |
0.602 |
303(76.9) 91(23.1) |
117(76.0) 37(24.0) |
0.817 | ||
Tumor size | 0.072 | 0.470 | ||||||
≤4.75 | 183(75.6) | 33(63.5) | 276(70.1) | 103(66.9) | ||||
>4.75 | 59(24.4) | 19(26.5) | 118(29.9) | 51(33.1) | ||||
Histologic type Signet-ring cell carcinoma |
40(16.5) |
7(13.5) |
0.609 |
41(10.4) |
10(6.5) |
0.170 | ||
Differentiated | 199(82.2) | 45(86.5) | 341(86.5) | 142(92.2) | ||||
Undifferentiated | 3(1.3) | 0(0.0) | 12(3.1) | 2(1.3) | ||||
Pathologic type | 0.033* | 0.038 | 0.552 | |||||
Ulcerative type | 193(79.8) | 48(92.3) | 316(80.2) | 120(77.9) | ||||
Non-ulcerative type | 49(20.2) | 4(7.7) | 78(19.8) | 34(22.1) | ||||
TNM stage | 0.062 | 0.018* | ||||||
0/I | 89(36.8) | 11(21.2) | 129(32.7) | 38(24.7) | ||||
II | 36(14.9) | 7(13.5) | 67(17.0) | 18(11.7) | ||||
III | 117(48.3) | 34(65.3) | 198(50.3) | 98(63.6) | ||||
N stage N0 N1 N2 N3 |
114(47.1) 30(12.4) 43(17.8) 55(22.7) |
18(34.6) 6(11.5) 8(15.4) 20(38.5) |
0.121 |
176(44.7) 51(12.9) 65(16.5) 102(25.9) |
54(35.1) 24(15.6) 32(20.8) 44(28.5) |
0.217 | ||
T stage Tis/1 T2 T3 T4 |
58(24.0) 50(20.7) 46(19.0) 88(36.3) |
5(9.6) 10(19.2) 10(19.2) 26(50) |
0.162 |
83(21.1) 91(23.1) 79(20.1) 141(35.7) |
19(12.3) 32(20.8) 30(19.5) 73(47.4) |
0.034* | ||
Tumor location | 0.156 | 0.246 | ||||||
Cardia | 29(12.0) | 11(21.2) | 83(21.1) | 32(20.8) | ||||
Corpus | 55(22.7) | 8(15.4) | 86(21.8) | 44(28.6) | ||||
Pylorus | 157(64.9) | 32(61.5) | 223(56.6) | 76(49.4) | ||||
Total | 1(0.4) | 1(1.9) | 2(0.5) | 2(1.2) | ||||
Anastomotic method | 0.284 | 0.005* | ||||||
Billroth I | 146(60.3) | 26(50) | 224(56.9) | 67(43.5) | ||||
Billroth II | 41(16.9) | 9(17.3) | 67(17.0) | 26(16.9) | ||||
Roux-en-y | 55(22.7) | 17(32.7) | 103(26.1) | 61(39.6) | ||||
Total gastrectomy No Yes |
199(82.2) 43(17.8) |
39(75.0) 13(25.0) |
0.228 |
316(80.2) 78(19.8) |
103(66.9) 51(33.1) |
0.001* | ||
Combined operation | 0.445 | 0.142 | ||||||
No | 226(93.4) | 47(90.4) | 355(85.0) | 132(85.7) | ||||
Yes | 16(6.6) | 5(9.6) | 39(15.0) | 22(14.3) | ||||
Surgical method Open Laparoscopic |
212(87.6) 30(12.4) |
51(98.1) 1(1.9) |
0.026* |
348(88.3) 46(11.7) |
143(92.9) 11(7.1) |
0.118 |
Note: *Statistically significant (P< 0.05).
Abbreviations: BMI, body mass index; TNM, Tumor-Lymph, Node, Metastasis.